$58.71
-2.19-3.6%
Last update: Aug 26, 12:18 PM
CRISPR Therapeutics AG
CRSPNASDAQ
PRO
CRISPR Therapeutics Earnings & Forecasts
CRISPR Therapeutics (CRSP) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
CRISPR Therapeutics Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.18 | $-1.22 | $-1.20 | $-1.30 |
| Actual | $-0.94 | $-1.28 | $-1.37 | $-1.17 |
| Surprise | +20.3% | -4.92% | -14.2% | +10.0% |
| Revenue | ||||
| Estimate | $7.1M | $5.1M | $3.9M | $8.1M |
| Actual | $10.2M | $1.5M | $864000 | $889000 |
| Surprise | +43.0% | -71.2% | -78.0% | -89.0% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.05 | $-1.17 | $-0.89 | $-0.86 |
| Revenue | ||||
| Consensus | $14.8M | $14.4M | — | — |
